Last reviewed · How we verify
NCT06975631
Post-market Study on TrHCROSS® in Knee Osteoarthritis After a Single Injection
NA trial testing TrHCROSS® in Knee Osteoarthritis in 60 participants. Completed in 14 February 2024.
10 August 2023
Quick facts
| Lead sponsor | i+Med S.Coop. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 2 June 2022 |
| Primary completion | 10 August 2023 |
| Estimated completion | 14 February 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- TrHCROSS®
- Hyalone®
Conditions studied
- Knee Osteoarthritis — all drugs for Knee Osteoarthritis →
Sponsor
i+Med S.Coop. — full company profile →
Who can join
Adults 18 to 80, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Double-blind study assessing the safety and efficacy of TrHCROSS® in knee osteoarthritis, compared to Hyalone®, using scales such as WOMAC, VAS, and KOOS. The population includes 60 symptomatic patients with mild to moderate KOA (Kellgren-Lawrence II or III) who have not responded adequately to non-pharmacological treatments or simple analgesics.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06975631
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Knee Osteoarthritis
Currently open trials in the same condition.
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
- NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
- NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
- NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting
Other i+Med S.Coop. trials
Trials by the same sponsor.
- NCT07402395 — Clinical Study on the Safety and Efficacy of an Injectable Hyaluronic Acid for Improving the Aesthetic Rejuvenation of t · NA · completed
- NCT07533461 — Safety Test Under Gynecological Control to Evaluate Skin Acceptability of the Product in Female Volunteers · NA · completed
- NCT07533474 — Human In Use Test of GINPI-HP-004 in Healthy Adults · NA · completed
- NCT07301658 — Efficacy and Safety of Revodiol Calming Cream® in Atopic Dermatitis. · NA · completed
- NCT06732830 — Clinical Trial to Assess the Effectiveness of I+Med's DayDrop Advanced Ophthalmic Drop · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06975631 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by i+Med S.Coop.
- Last refreshed: 21 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06975631.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing